GPR160 is a potential biomarker associated with prostate cancer
Wanjing Guo,
Junyu Zhang,
Yan Zhou,
Caihong Zhou,
Yunjie Yang,
Zhaotong Cong,
Jibin Dong,
Dehua Yang,
Bo Dai,
Ming-Wei Wang
Affiliations
Wanjing Guo
The National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS)
Junyu Zhang
Department of Urology, Fudan University Shanghai Cancer Center
Yan Zhou
The National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS)
Caihong Zhou
The National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS)
Yunjie Yang
Department of Urology, Fudan University Shanghai Cancer Center
Zhaotong Cong
School of Pharmacy, Fudan University
Jibin Dong
School of Pharmacy, Fudan University
Dehua Yang
The National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS)
Bo Dai
Department of Urology, Fudan University Shanghai Cancer Center
Ming-Wei Wang
The National Center for Drug Screening and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS)
